Results 121 to 130 of about 732 (166)

Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacy. [PDF]

open access: yesRheumatology (Oxford)
Veldkamp SR   +18 more
europepmc   +1 more source

Subclinical Atherosclerosis Risk Can Be Predicted in Female Patients With Systemic Lupus Erythematosus Using Metabolomic Signatures: An Observational Study. [PDF]

open access: yesJ Am Heart Assoc
Woodridge L   +12 more
europepmc   +1 more source

Type I interferon signature: a quantitative standardized method for clinical application. [PDF]

open access: yesClin Exp Immunol
Tesser A   +12 more
europepmc   +1 more source

Therapeutic potential of TAM receptors in autoimmune diseases: insights from original studies. [PDF]

open access: yesOxf Open Immunol
Adedayo SI   +8 more
europepmc   +1 more source

Limited Sensitivity and Specificity of the ACR/EULAR-2019 Classification Criteria for SLE in JSLE?—Observations From the UK JSLE Cohort Study [PDF]

open access: yesRheumatology, 2021
Abstract Objectives This study aimed to test the performance of the new ACR and EULAR criteria, that include ANA positivity as entry criterion, in JSLE. Methods Performance of the ACR/EULAR-2019 criteria were compared with Systemic ...
Robert J Moots   +2 more
exaly   +6 more sources

1675 Real World Treatment of Juvenile Systemic Lupus Erythematosus (JSLE): Evidence From the UK JSLE Cohort Study [PDF]

open access: yesArchives of Disease in Childhood, 2021
Christian M Hedrich   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy